Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.
暂无分享,去创建一个
B. Erickson | A. Rashid | C. Willett | L. Kachnic | N. Meropol | E. Mitchell | P. Anné | J. C. Watson | K. Winter | M. Haddock | Stuart J. Wong | J. Pollock | R. J. Lee